Target intelligence / Profile preview

Ubiquitin specific peptidase 32 pseudogene 1 (USP32P1)

Target: USP32P1
Molecular classification: Other

Overview

Ubiquitin specific peptidase 32 pseudogene 1 (USP32P1) is classified as a pseudogene and does not code for a functional protein. While related to the ubiquitin specific peptidase 32 (USP32) gene family, USP32P1 itself is not known to have any biological activity or established role as a therapeutic target. There is no evidence for involvement in disease, biological pathways, or interaction with drugs[1][2][6]. Its designation as a pseudogene means it is generally considered non-functional and is not investigated as a target for therapy or drug development[1][2][6].

Other names: TL132

Beyond the preview

Go deeper on Ubiquitin specific peptidase 32 pseudogene 1 (USP32P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin specific peptidase 32 pseudogene 1 (USP32P1).

Explore the full profile